Search results
Author(s):
Babar Basir
,
Karim Al-Azizi
Added:
1 month ago
ACC 2026 — Drs Karim Al-Azizi (Baylor Scott & White The Heart Hospital, Plano) and Babar Basir (Henry Ford Hospital, US) deliver a short, front-line interventional view of the STEMI Door-to-Unload (STEMI-DTU) trial (NCT03000270), making this an efficient 5-minute update for cardiologists and cath lab teams.STEMI-DTU randomised haemodynamically stable patients aged 18–85 years with a first acute…
View more
The Asia Pacific Cardiovascular Research (ASPIRE) Network
Author(s):
Clement Lau
,
Philip D Adamson
,
Nicholas Chew
,
et al
Added:
8 months ago
Short Communication
Lipid Clinics: Enablers and Barriers
Author(s):
Azhari Rosman
,
Ahmad Khairuddin Mohamed Yusof
,
Hafidz Abd Hadi
,
et al
Added:
5 months ago
Review Article
Author(s):
Deepak L Bhatt
Added:
1 month ago
ACC 2026 — Dr Deepak Bhatt (Mount Sinai Fuster Heart Hospital, US) delivers his expert verdict on three late-breaking clinical trials from ACC 2026 that are poised to influence cardiovascular care and future clinical guidelines.Dr Bhatt highlights data updates from the SURPASS-CVOT trial, exploring expanded cardiometabolic findings with tirzepatide versus dulaglutide, discusses the HI-PEITHO…
View more
Clinical Features and the Efficacy of Thrombolytic Therapy in de Winter
Author(s):
Nirmalatiban Parthiban
,
Fiona Boland
,
Huzairi Sani
Added:
1 year ago
Systematic Review
Author(s):
Luigi Di Biase
Added:
3 months ago
Arrhythmia Academy Editor-in-Chief Dr Luigi Di Biase shares his expert perspective on the most practice-changing clinical trials emerging from the latest advances in atrial fibrillation management.In this highlights discussion, Dr Di Biase distills the key evidence that is reshaping clinical decision-making in AF ablation, anticoagulation strategies, and rhythm control approaches. Drawing from…
View more
Author(s):
Mirvat Alasnag
Added:
6 months ago
TCT 2025 - In this insightful highlights video from TCT 2025, Dr Mirvat Alasnag (King Fahad Armed Forces Hospital, SA) provides expert commentary on the most impactful late-breaking clinical trials presented at this year's conference.The commentary distills the most important late-breaking trials in structural cardiology, coronary interventions, and artificial intelligence presented at TCT 2025…
View more
Author(s):
Michael J Mack
Added:
6 months ago
TCT 2025 - Long-term follow-up of the PARTNER 3 trial showed no safety concerns for transcatheter aortic-valve replacement (TAVR) compared to surgical treatment of aortic stenosis (AS).Dr Michael Mack (Baylor Scott & White Heart Hospital, Plano, US) joins us to share the clinical and echocardiographic outcomes from the seven-year follow-up of the PARTNER 3 low-risk randomised trial (NCT02675114)…
View more
Prediction of Subclinical Coronary Atherosclerosis
Author(s):
Chris Lenselink
,
Jonathan Yap
,
Weng Khong Lim
,
et al
Added:
2 weeks ago
Original Research
MY-MDHFC Study
Author(s):
Hwei Sung Ling
,
Bui Khiong Chung
,
Alan Yean Yip Fong
,
et al
Added:
1 month ago
Original Research